glp-1 near iowa city Injections in Swea City, (IA) PolitiFact | Realities of life

Gabe, Aaron D

(KFFs report says 12 states and not 13 because it was released before North Carolina began covering the drugs for obesity.) The report notes that South Carolina plans to add coverage for obesity at the end of 2024, and Connecticut has a legislative mandate to add coverage but it has not yet been implemented

Purpose-built for physicians Human, exendin-based GLP-1 receptor agonists similarly reduce CV, renal risk in diabetes A pooled study assessing trials of eight GLP-1 receptor agonists showed all reduce risk for a combined endpoint of major adverse cardiovascular events, regardless of structural homology to human GLP-1, as well as individual CV components

However, the DPP/DPPOS 21-year follow-up did not find a statistically significant reduction in major cardiovascular events with metformin versus placebo, though favorable trends in risk factors were observed

A large study suggests GLP-1 drugs used for diabetes and obesity may be linked to reduced addiction risk and fewer overdoses, though more research is needed

Monitoring for signs of adequate hydration is important